about
Potential developmental neurotoxicity of pesticides used in EuropeThe relationships between pesticide metabolites and neurobehavioral test performance in the Third National Health and Nutrition Examination SurveyFunctional consequences of repeated organophosphate exposure: potential non-cholinergic mechanismsGulf War agent exposure causes impairment of long-term memory formation and neuropathological changes in a mouse model of Gulf War IllnessPeripheral nervous system function and organophosphate pesticide use among licensed pesticide applicators in the Agricultural Health StudyOccupational exposure to neurotoxic substances in Asian countries - challenges and approachesChronic impairments in spatial learning and memory in rats previously exposed to chlorpyrfos or diisopropylfluorophosphate.Delayed polyneuropathy in farm sprayers due to chronic low dose pesticide exposureAnimal models of peripheral neuropathy due to environmental toxicantsClinical features of organophosphate poisoning: A review of different classification systems and approachesNeurotoxicity in Preclinical Models of Occupational Exposure to Organophosphorus CompoundsToxicology of organophosphorus compounds in view of an increasing terrorist threat.Alterations in gene expression in Caenorhabditis elegans associated with organophosphate pesticide intoxication and recovery.Diisopropylfluorophosphate Impairs the Transport of Membrane-Bound Organelles in Rat Cortical AxonsDistinct patterns of gene and protein expression elicited by organophosphorus pesticides in Caenorhabditis elegans.Repeated exposures to diisopropylfluorophosphate result in impairments of sustained attention and persistent alterations of inhibitory response control in rats.A randomized phase I study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of Alzheimer's disease.Chemical genetics screening reveals KIAA1363 as a cytokine-lowering target.Motor neuron disease due to neuropathy target esterase mutation: enzyme analysis of fibroblasts from human subjects yields insights into pathogenesis.Constructs of human neuropathy target esterase catalytic domain containing mutations related to motor neuron disease have altered enzymatic properties.Preparation and characterization of diethoxy- and monoethoxy phosphylated ('aged') serine haptens and use in the production of monoclonal antibodies.Delayed reduction of hippocampal synaptic transmission and spines following exposure to repeated subclinical doses of organophosphorus pesticide in adult mice.The Long-Term Effects of Organophosphates Poisoning as a Risk Factor of CVDs: A Nationwide Population-Based Cohort StudyAcute Anticholinesterase Pesticide Poisoning Caused a Long-Term Mortality Increase: A Nationwide Population-Based Cohort StudyThe History, Status, Gaps, and Future Directions of Neurotoxicology in ChinaNeurotoxicity of pesticides.Delayed neuropathy due to organophosphate insecticide injection in an attempt to commit suicide.Swiss Cheese, a protein involved in progressive neurodegeneration, acts as a noncanonical regulatory subunit for PKA-C3.Protection of DFP-induced oxidative damage and neurodegeneration by antioxidants and NMDA receptor antagonist.Health symptoms related to pesticide exposure and agricultural tasks among rice farmers from Northern Thailand.Genomic and phenotypic alterations of the neuronal-like cells derived from human embryonal carcinoma stem cells (NT2) caused by exposure to organophosphorus compounds paraoxon and mipafox.Pharmacokinetic Potentiation of Mixed Organophosphate and Pyrethroid Poison Leading to Prolonged Delayed Neuropathy.Delayed onset neuropathy along with recurrent laryngeal nerve palsy due to organophosphate poisoning and the role of physiotherapy rehabilitation.Neurotranmission systems as targets for toxicants: a review.Behavioral and Immunohistochemical Study of the Effects of Subchronic and Chronic Exposure to Glyphosate in Mice.Organophosphate neurotoxicity to the voluntary motor system on the trail of environment-caused amyotrophic lateral sclerosis: the known, the misknown, and the unknown.Acetylcholinesterase and neuropathy target esterase activities in 11 cases of symptomatic flight crew members after fume events.Neuropathy target esterase in mouse whole blood as a biomarker of exposure to neuropathic organophosphorus compounds.Pulmonary delivery of an aerosolized recombinant human butyrylcholinesterase pretreatment protects against aerosolized paraoxon in macaques.Neuropathic pain-like alterations in muscle nociceptor function associated with vibration-induced muscle pain
P2860
Q21245813-512DF5A8-E04F-4F4E-9287-EA9F321E79C4Q23912373-AAAF1E18-20E3-4823-848E-0257EED42175Q27012629-D5E8CB1D-C334-4078-836E-0CF7B814FF7EQ27312033-D186AB7B-7FDB-4CDC-ABA6-5B8AC1C00DDEQ28383848-CD0E2714-F3FC-437F-AC15-76CE49ABC06AQ28384346-579E33FA-EF99-4F01-97A4-FA681D82DAD2Q28385158-3750EE7E-A248-4702-A823-4A8153D0B5D4Q28389470-D5E5AFE2-E335-41F8-BB61-900E61B66329Q28394003-B06AC422-0044-4DC6-B400-602BA42D6AA4Q28397902-E8598AB5-DAFD-4B98-A5E6-BE0EB648BF26Q29248216-254E188B-494C-4C12-9887-392E9EFD53C5Q30151953-27A55192-DF5A-433F-8C87-31CCB8CFC366Q30543965-D2DCA83D-F021-496E-ABD9-538D9EC95887Q30717808-6B38E795-E80C-443C-BF36-2C038AD36305Q33436423-08B5AA9F-3BBC-4E19-9C80-50D9F68660C0Q33905502-E8CF096E-EC20-44B2-8EFC-C5FA430DD08CQ34309353-0B471CFB-C3C1-4C8E-AE99-D198C30224C2Q34756802-C987A54A-7BDC-4892-946D-0D843BB0B422Q35026581-C21D83EF-871E-4117-8248-6E3467595F85Q35026594-BA2500DE-4059-4B95-AEF3-BA84375093CDQ35220384-9AA94EE4-1562-45E4-AE71-2DE1151C0E28Q35639163-C6DCD5AF-D2BB-4597-A341-E90F39C76C78Q35764513-9AA3415E-8E1D-4916-9ED2-838CA387D808Q36009314-0926A65A-051F-4ABC-AAD9-945CF1116771Q36968146-EDE14861-8015-4E03-B887-E853F822FB8EQ37010951-525FFE25-73C4-467E-97BA-70C71F834197Q37126420-82290FDD-C53B-42B2-AC0C-64B19A24D221Q37295503-8EB6F879-36B3-4836-9186-6597206975C6Q37366817-19CE78FE-474C-4BB4-B4F7-528EFFFE12D8Q37471892-2BEA2279-D42B-416C-B4B1-C2D098C02D56Q37535553-B8AB03B2-32FE-479C-B84D-204B67FDA350Q37543026-C04401BB-4AC5-4BCC-B7B1-9AEAC7AF90AFQ37618569-674F0B12-52AE-4B1C-B1A1-06F553A40F99Q38137691-575F019B-0D15-429F-BD76-6D37DA0FECA3Q38604935-2C30FFE8-6E02-46DD-92D6-52A2F8262783Q38772508-EEC009E4-ECC1-4B39-BA10-4BF8C108287EQ39125122-1022DC6D-4C38-44D8-995C-1FC3912F5F6EQ39926335-B73BEB02-917F-4FD5-AEA8-1DBE2C8430E8Q41287188-DA86808C-ABC7-4410-A2A9-EFECBFE1B8ABQ42432852-20860CE6-F989-4F5D-A104-8CB1B0AB3CB1
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Organophosphate-induced delayed polyneuropathy.
@ast
Organophosphate-induced delayed polyneuropathy.
@en
Organophosphate-induced delayed polyneuropathy.
@nl
type
label
Organophosphate-induced delayed polyneuropathy.
@ast
Organophosphate-induced delayed polyneuropathy.
@en
Organophosphate-induced delayed polyneuropathy.
@nl
prefLabel
Organophosphate-induced delayed polyneuropathy.
@ast
Organophosphate-induced delayed polyneuropathy.
@en
Organophosphate-induced delayed polyneuropathy.
@nl
P2860
P1476
Organophosphate-induced delayed polyneuropathy.
@en
P2093
Marcello Lotti
P2860
P356
10.2165/00139709-200524010-00003
P577
2005-01-01T00:00:00Z
P6179
1040280432